Form 4: National Health Investors SVP Exercises Stock Options and Disposes of Shares for Tax Obligations
SEC Form 4 Filing
Kristin Sallee Gaines, SVP/Chief Transaction Officer of National Health Investors, exercised stock options and disposed of shares to cover the exercise price and taxes on September 25, 2024.
Summary
- On September 25, 2024, Kristin Sallee Gaines, SVP/Chief Transaction Officer of National Health Investors Inc. (NHI), exercised stock options.
- The options were granted on February 25, 2021, with an exercise price of $69.2.
- Gaines acquired 18,333 shares, 18,333 shares and 18,334 shares of common stock through the exercise of these options.
- Simultaneously, 48,665 shares were disposed of at a price of $84.66 to cover the exercise price and tax obligations.
- Following these transactions, Gaines directly owns 57,944 shares of NHI common stock.
- The exercised shares are subject to a Lock-Up Agreement.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard insider transaction related to stock options and tax obligations, with no inherent positive or negative implications for the company's performance.
Management Comments
- The transaction was completed subsequent to the execution of a Lock-Up Agreement and shares received are subject to the provisions of that agreement.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It is common for executives to exercise stock options and sell a portion of the acquired shares to cover the associated tax liabilities.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders.
- The exercise of stock options and subsequent sale of shares for tax purposes is a common financial planning strategy among executives.
- The specific details of the transactions (number of shares, prices) are unique to the individual and the company's stock option plan.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders.
- It provides transparency to shareholders regarding insider transactions.
- The Lock-Up Agreement may restrict the executive's ability to sell the acquired shares for a certain period.
Key Dates
| Date | Description |
|---|---|
| 02/21/2020 | Grant date for some stock options with an exercise price of $90.79 |
| 02/25/2021 | Grant date for some stock options with an exercise price of $69.2 |
| 02/25/2022 | Grant date for some stock options with an exercise price of $53.41 |
| 02/24/2023 | Grant date for some stock options with an exercise price of $54.73 |
| 02/23/2024 | Grant date for some stock options with an exercise price of $57.76 |
| 09/25/2024 | Date of stock option exercise and share disposal |
| 09/26/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.